Effects and safety of beta-blocker withdrawal among patients undergoing transcatheter aortic valve replacement

Back

ESC Premium Access

Effects and safety of beta-blocker withdrawal among patients undergoing transcatheter aortic valve replacement

Session: Poster Session 6 - Clinical impact of intervention in valve disease

Topic: Intervention

Speaker: Doctor A. Younis (Rochester, US)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Arwa Younis

University of Rochester, Rochester (United States of America)

0 follower

8 more presentations in this session

Risk of major AV conduction disturbances after TAVR attributable to aortic calcium burden

Speaker: Doctor P. Marcos-Alberca (Madrid, ES)

Access

Abstract

Slides

Reduction in sympathetic activity in patients with aortic stenosis after transcatheter aortic valve implantation

Speaker: Associate Professor K. Mert (Eskisehir, TR)

Access

Abstract

Slides

Impact of the repositionable Evolut R CoreValve on the need for permanent pacemaker after transcatheter aortic valve implantation in patients with severe aortic stenosis

Speaker: Professor M. Romero (Cordoba, ES)

Access

Abstract

Slides

Treatment of severe aortic stenosis by transcatheter aortic valve replacement (TAVR) is associated with a decrease of pre-existing depression and anxiety

Speaker: Doctor G. Dannberg (Jena, DE)

Access

Abstract

National trends, outcomes and complications of transcatheter pulmonary valve replacement; a population study

Speaker: Doctor A. Tsangaris (Minneapolis, US)

Access

Abstract

Slides

Access the full session

Poster Session 6 - Clinical impact of intervention in valve disease

Speakers: Doctor A. Younis, Doctor P. Marcos-Alberca, Associate Professor K. Mert, Professor M. Romero, Doctor G. Dannberg...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources